Liu An
Hubei University
2 Papers
Liu An is an academic researcher from Hubei University. The author has contributed to research in topics: Fatty liver & Medicine. The author has co-authored 1 publications.
Chat about Author
Papers
Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling.
Jia-Yao Yang,Wei Ma,Qunchao Mei,Juefei Song,Lei Shu,Shu Zhang,Chenyu Li,Liu An,Nianlong Du,Zhao-Hong Shi +9 more
TL;DR: It was shown that FLD significantly improved NAFLD by regulating the immune system to induce the release of interleukin-10 (IL-10), interferon-α (IFN-α), and IFN-β through activating p53 signaling and inhibiting PPARG signaling in vivo and in vitro.
14
Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling
Jia-Yao Yang,Ying Zhang,Hong Yi,Yan Liao,Lei Shu,Shu Zhang,Chenyu Li,Liu An,Nianlong Du,Zhao-Hong Shi,Wei Ma +10 more
TL;DR: Findings provide novel insights into the mechanisms whereby this compound acts as an anti-inflammatory agent and highlight the potential application of FLD in the treatment of acute liver failure (ALF).